E. Missiaglia

Discipline

Psychologie (2) Histoire, Philosophie et Sociologie des sciences (1) Economies et finances (1)

Type de document

Articles (19)

Co-auteur

Date

Source

Mot-clé

Human beings (13) Lymphomas (9) gène (7) mutation (6) Treatment (6) Cases (6) Genes (6) Expression (6) Older people (6) Cases (6) Mutation (6) thérapie (5) analyse (5) Therapeutics (5) Patients (5) Analysis (5) Patients (5) maladie (4) survie (4) Transcription (4) Survival (4) Proteins (4) Inhibition (4) Impact (4) Immunohistochemistry (4) Cells (4) Cancer (4) Addition (4) Use (4) Transcription (4)

Documents écrit par E. Missiaglia (19) | parle de E. Missiaglia (0)

Response and Resistance to Trametinib in MAP2K1-Mutant Triple-Negative Melanoma.
F.S. Krebs et al. (24 févr. 2023)
Monomorphic epitheliotropic intestinal T-cell lymphoma comprises morphologic and genomic heterogeneity impacting outcome.
L. Veloza et al. (1 janv. 2023)
Integrative analysis of a phase 2 trial combining lenalidomide with CHOP in angioimmunoblastic T-cell lymphoma.
F. Lemonnier et al. (26 janv. 2021)
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma in Asia Frequently Shows SETD2 Alterations.
S. Tomita et al. (27 nov. 2020)
Trametinib Induces the Stabilization of a Dual GNAQ p.Gly48Leu- and FGFR4 p.Cys172Gly-Mutated Uveal Melanoma. The Role of Molecular Modelling in Personalized Oncology.
F.S. Krebs et al. (28 oct. 2020)
Gallbladder Mixed Neuroendocrine-Non-neuroendocrine Neoplasm (MiNEN) Arising in Intracholecystic Papillary Neoplasm: Clinicopathologic and Molecular Analysis of a Case and Review of the Literature.
A. Sciarra et al.
Acinar cell carcinoma of the pancreas with thyroid-like follicular features: first description of a new diagnostic challenging subtype.
C. Saglietti et al.
VGLL3 operates via TEAD1, TEAD3 and TEAD4 to influence myogenesis in skeletal muscle.
N. Figeac et al. (5 juil. 2019)
Dual JAK1 and STAT3 mutations in a breast implant-associated anaplastic large cell lymphoma.
A. Letourneau et al.
RNA fusions involving CD28 are rare in peripheral T-cell lymphomas and concentrate mainly in those derived from follicular helper T cells.
D. Vallois et al.
Comment on "MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma".
S. Voruz et al.
Response to MEK inhibition with trametinib and tyrosine kinase inhibition with imatinib in multifocal histiocytic sarcoma.
S. Voruz et al.
Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.
M.P. Dobay et al.
The Hippo effector TAZ (WWTR1) transforms myoblasts and TAZ abundance is associated with reduced survival in embryonal rhabdomyosarcoma.
A. Mohamed et al.
Type II enteropathy-associated T-cell lymphoma features a unique genomic profile with highly recurrent SETD2 alterations.
A. Roberti et al. (2016)
Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
D. Vallois et al. (2016)
The consensus molecular subtypes of colorectal cancer.
J. Guinney et al. (2015)
Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels.
C. Bossard et al. (6 nov. 2014)
JARID2 is a direct target of the PAX3-FOXO1 fusion protein and inhibits myogenic differentiation of rhabdomyosarcoma cells.
Z.S. Walters et al. (2014)